Northwest Biotherapeutics Management
Management criteria checks 3/4
Northwest Biotherapeutics' CEO is Linda Powers, appointed in Jun 2011, has a tenure of 12.92 years. total yearly compensation is $1.10M, comprised of 63.6% salary and 36.4% bonuses, including company stock and options. directly owns 2.44% of the company’s shares, worth $13.53M. The average tenure of the management team and the board of directors is 12.9 years and 18.7 years respectively.
Key information
Linda Powers
Chief executive officer
US$1.1m
Total compensation
| CEO salary percentage | 63.6% |
| CEO tenure | 12.9yrs |
| CEO ownership | 2.4% |
| Management average tenure | 12.9yrs |
| Board average tenure | 18.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$64m |
| Sep 30 2023 | n/a | n/a | -US$73m |
| Jun 30 2023 | n/a | n/a | -US$87m |
| Mar 31 2023 | n/a | n/a | -US$102m |
| Dec 31 2022 | US$1m | US$700k | -US$105m |
| Sep 30 2022 | n/a | n/a | US$57m |
| Jun 30 2022 | n/a | n/a | US$135m |
| Mar 31 2022 | n/a | n/a | US$169m |
| Dec 31 2021 | US$1m | US$700k | US$179m |
| Sep 30 2021 | n/a | n/a | -US$234m |
| Jun 30 2021 | n/a | n/a | -US$474m |
| Mar 31 2021 | n/a | n/a | -US$537m |
| Dec 31 2020 | US$18m | US$700k | -US$530m |
| Sep 30 2020 | n/a | n/a | -US$243m |
| Jun 30 2020 | n/a | n/a | -US$56m |
| Mar 31 2020 | n/a | n/a | US$3m |
| Dec 31 2019 | US$802k | US$502k | -US$21m |
| Sep 30 2019 | n/a | n/a | -US$33m |
| Jun 30 2019 | n/a | n/a | -US$18m |
| Mar 31 2019 | n/a | n/a | -US$43m |
| Dec 31 2018 | US$7m | US$502k | -US$54m |
| Sep 30 2018 | n/a | n/a | -US$76m |
| Jun 30 2018 | n/a | n/a | -US$108m |
| Mar 31 2018 | n/a | n/a | -US$93m |
| Dec 31 2017 | US$502k | US$502k | -US$74m |
Compensation vs Market: Linda's total compensation ($USD1.10M) is below average for companies of similar size in the US market ($USD2.41M).
Compensation vs Earnings: Linda's compensation has increased whilst the company is unprofitable.
CEO
Linda Powers (67 yo)
12.9yrs
Tenure
US$1,100,000
Compensation
Ms. Linda F. Powers, J.D., has been Chief Financial Officer and Chief Accounting Officer at Northwest Biotherapeutics, Inc. since June 8, 2020. Ms. Powers has been the Chief Executive Officer and President...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairperson | 12.9yrs | US$1.10m | 2.44% $ 13.5m | |
| Founder | 26.3yrs | US$450.00k | 0.81% $ 4.5m | |
| Chief Technical Officer | 17.3yrs | US$597.50k | 0.0099% $ 54.9k | |
| Senior VP & General Counsel | 4.7yrs | US$825.00k | 0.014% $ 79.5k | |
| Vice President of Investor Relations | 5.3yrs | no data | no data |
12.9yrs
Average Tenure
72.5yo
Average Age
Experienced Management: NWBO's management team is seasoned and experienced (12.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairperson | 17yrs | US$1.10m | 2.44% $ 13.5m | |
| Founder | 26.3yrs | US$450.00k | 0.81% $ 4.5m | |
| Member of Clinical Advisory Board | 18.7yrs | no data | no data | |
| Member of Clinical Advisory Board | 18.7yrs | no data | no data | |
| Member of Scientific Advisory Board | 18.7yrs | no data | no data | |
| Member of Clinical Advisory Board | 18.7yrs | no data | no data | |
| Member of Clinical Advisory Board | 18.7yrs | no data | no data | |
| Independent Director | 12.1yrs | US$150.00k | 2.01% $ 11.1m | |
| Independent Director | less than a year | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 8.3yrs | US$150.00k | 0.54% $ 3.0m |
18.7yrs
Average Tenure
68.5yo
Average Age
Experienced Board: NWBO's board of directors are seasoned and experienced ( 18.7 years average tenure).